News
The deal includes a primary capital infusion of Rs 600 crore and a secondary purchase from existing shareholders, including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback